rs7359662
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_020877.5(DNAH2):āc.5265C>Gā(p.Val1755=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.908 in 1,613,820 control chromosomes in the GnomAD database, including 672,803 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.81 ( 52302 hom., cov: 31)
Exomes š: 0.92 ( 620501 hom. )
Consequence
DNAH2
NM_020877.5 synonymous
NM_020877.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0290
Genes affected
DNAH2 (HGNC:2948): (dynein axonemal heavy chain 2) Dyneins are microtubule-associated motor protein complexes composed of several heavy, light, and intermediate chains. The axonemal dyneins, found in cilia and flagella, are components of the outer and inner dynein arms attached to the peripheral microtubule doublets. DNAH2 is an axonemal inner arm dynein heavy chain (Chapelin et al., 1997 [PubMed 9256245]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 17-7778094-C-G is Benign according to our data. Variant chr17-7778094-C-G is described in ClinVar as [Benign]. Clinvar id is 402709.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.029 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.934 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH2 | NM_020877.5 | c.5265C>G | p.Val1755= | synonymous_variant | 34/86 | ENST00000572933.6 | NP_065928.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH2 | ENST00000572933.6 | c.5265C>G | p.Val1755= | synonymous_variant | 34/86 | 2 | NM_020877.5 | ENSP00000458355 | P1 | |
DNAH2 | ENST00000389173.6 | c.5265C>G | p.Val1755= | synonymous_variant | 33/85 | 2 | ENSP00000373825 | P1 | ||
DNAH2 | ENST00000574518.1 | c.*1641C>G | 3_prime_UTR_variant, NMD_transcript_variant | 15/22 | 2 | ENSP00000461273 |
Frequencies
GnomAD3 genomes AF: 0.806 AC: 122591AN: 152006Hom.: 52282 Cov.: 31
GnomAD3 genomes
AF:
AC:
122591
AN:
152006
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.881 AC: 221642AN: 251442Hom.: 99324 AF XY: 0.888 AC XY: 120722AN XY: 135890
GnomAD3 exomes
AF:
AC:
221642
AN:
251442
Hom.:
AF XY:
AC XY:
120722
AN XY:
135890
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.918 AC: 1342151AN: 1461696Hom.: 620501 Cov.: 49 AF XY: 0.918 AC XY: 667388AN XY: 727178
GnomAD4 exome
AF:
AC:
1342151
AN:
1461696
Hom.:
Cov.:
49
AF XY:
AC XY:
667388
AN XY:
727178
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.806 AC: 122657AN: 152124Hom.: 52302 Cov.: 31 AF XY: 0.811 AC XY: 60306AN XY: 74374
GnomAD4 genome
AF:
AC:
122657
AN:
152124
Hom.:
Cov.:
31
AF XY:
AC XY:
60306
AN XY:
74374
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2952
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
DNAH2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 17, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at